Protein carbonyls in decidua and placenta of pre-eclamptic women as markers for oxidative stress

被引:107
作者
Zusterzeel, PLM
Rütten, H
Roelofs, HMJ
Peters, WHM
Steegers, EAP
机构
[1] Univ Nijmegen Hosp, Dept Obstet & Gynaecol, NL-6500 HB Nijmegen, Netherlands
[2] Univ Nijmegen Hosp, Dept Gastroenterol, NL-6500 HB Nijmegen, Netherlands
关键词
D O I
10.1053/plac.2000.0606
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Enhanced levels of reactive oxygen species (ROS) and decreased levels of antioxidants may contribute Co the development of pre-eclampsia. Protein carbonyls map be sensitive biomarkers for ROS-mediated protein damage, whereas the ferric reducing ability of plasma (FRAP) value may serve as marker for antioxidant capacity. Twenty-two healthy pregnant women and 50 patients with severe pre-eclampsia, 25 of whom with concurrent (haemolysis, elevated liver enzymes, low platelets) HELLP syndrome were investigated prospectively with respect to placental and decidual levels of protein carbonyls and FRAP antioxidant capacity. Measurements were evaluated using the Kruskal-Wallis or Mann-Whitney U-tests for comparison between groups, and the Wilcoxon signed-rank test fur comparison within groups. Spearman's correlation tests were used for correlation analyses. Placental and decidual protein carbonyl levels were higher in pre-eclampsia with HELLP than in healthy pregnancy, whereas FRAP levels were lower. Differences between pre-eclampsia and healthy pregnancy showed the same trend, but did not reach statistical significance. In pre-eclampsia with HELLP syndrome carbonyl levels as well as FRAP levels were significantly higher in placenta as compared with decidua. Higher levels of protein carbonyls and lower antioxidant capacity in both placenta and decidua in pre-eclampsia with concurrent HELLP syndrome as compared to healthy pregnancy may indicate that considerable ROS-mediated damage occurs in this disorder. (C) 2001 Harcourt Publishers Ltd.
引用
收藏
页码:213 / 219
页数:7
相关论文
共 35 条
[1]   The ferric reducing ability of plasma (FRAP) as a measure of ''antioxidant power'': The FRAP assay [J].
Benzie, IFF ;
Strain, JJ .
ANALYTICAL BIOCHEMISTRY, 1996, 239 (01) :70-76
[2]   Protein oxidation in aging, disease, and oxidative stress [J].
Berlett, BS ;
Stadtman, ER .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (33) :20313-20316
[3]   PREECLAMPSIA AND SERUM ANTIBODIES TO OXIDIZED LOW-DENSITY-LIPOPROTEIN [J].
BRANCH, DW ;
MITCHELL, MD ;
MILLER, E ;
PALINSKI, W ;
WITZTUM, JL .
LANCET, 1994, 343 (8898) :645-646
[4]   Protein carbonyl measurement by a sensitive ELISA method [J].
Buss, H ;
Chan, TP ;
Sluis, KB ;
Domigan, NM ;
Winterbourn, CC .
FREE RADICAL BIOLOGY AND MEDICINE, 1997, 23 (03) :361-366
[5]  
Cao GH, 1998, CLIN CHEM, V44, P1309
[6]  
DAVIDGE ST, 1992, OBSTET GYNECOL, V79, P897
[7]   Variability of lipid hydroperoxides in pregnant and nonpregnant women [J].
Gladen, BC ;
Tabacova, S ;
Baird, DD ;
Little, RE ;
Balabaeva, L .
REPRODUCTIVE TOXICOLOGY, 1999, 13 (01) :41-44
[8]   Antioxidants and human disease: A general introduction [J].
Halliwell, B .
NUTRITION REVIEWS, 1997, 55 (01) :S44-S49
[9]   Oxidative stress in the pathogenesis of preeclampsia [J].
Hubel, CA .
PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1999, 222 (03) :222-235
[10]  
ISHIHARA M, 1978, CLIN CHIM ACTA, V84, P1